Skip to content
Screener

Aktis Oncology, Inc. AKTS Q4 2024 earnings

Reported March 30, 2026

Revenue$1.7MMiss by $1.6M
EPS-$1.27Beat by $20.32
Revenue estimate$3.3M
EPS estimate-$21.59

Next report

Date not yet announced

FAQ

When did Aktis Oncology, Inc. report Q4 2024 earnings?
Aktis Oncology, Inc. (AKTS) reported Q4 2024 earnings on March 30, 2026.
What were Aktis Oncology, Inc.'s Q4 2024 revenue and EPS?
Aktis Oncology, Inc. reported revenue of $1.7M and eps of $-1.27 for Q4 2024.
Did Aktis Oncology, Inc. beat estimates in Q4 2024?
Revenue missed the consensus estimate of $3.3M by $1.6M. EPS beat the consensus estimate of $-21.59 by $20.32.
Where can I find Aktis Oncology, Inc.'s Q4 2024 SEC filings?
You can read the 8-K earnings release (0001193125-26-132524) directly on SEC EDGAR. The filing index links above go to sec.gov.